Skip to main content
SpringerLink
Log in

Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy

  • Original Investigations
  • Published:
Psychopharmacologia Aims and scope Submit manuscript

Summary

A dyskinetic syndrome consisting of involuntary grimaces, mastication, and propulsion of the tongue, in some cases in connection with akathisia and tasikinesia, due to electroconvulsive therapy, has been observed in 4 patients.

Moreover 29 cases have been observed, which were due to pharmacotherapy, in 15 cases with perphenazine, 10 cases with chlorpromazine, and one case with reserpine, and in 3 cases with various compounds.

12 patients are continuing the pharmacotherapy and dyskinesia disappeared in 2 of these cases after the dose had been reduced.

17 patients discontinued the treatment, but in 11 of these dyskinesia proved irreversible after an observation period of 4 to 22 months.

Dyskinesia generally occurred after prolonged treatment in elderly patients and patients with organic brain diseases.

The conclusion is drawn that prolonged administration of psychopharmaca, which cause neurological side effects, carries the risk of lesion of the central nervous system with irreversible dyskinesia, especially in elderly patients and patients with organic brain diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Christian, C. D., and G. Paulsen: Severe Motility disturbance after small Doses of Prochlorperazine. New Engl. J. Med. 259, 828–830 (1958).

    Google Scholar 

  • Delay, J., P. Deniker, R. Ropert, H. Beek, R. Barande et M. Eurieult: Syndromes neurologiques experimentaux et therapeutique psychiatrique. I. Effets neurologiques d'un nouveau neuroleptique majeur, le 7843 R.P. Presse méd. 67, 123–126 (1959).

    Google Scholar 

  • Freyhan, F. A.: Therapeutic implications of differential effects of new phenothiazine compounds. Amer. J. Psychiat. 115, 577–585 (1959).

    Google Scholar 

  • Shanon, J., M. Kaplan, M. Pierce and D. W. Ross: An interesting reaction to a tranquilizer: Tonic seizures with perphenazine (Trilafon). Amer. J. Psychiat. 114, 556 (1957).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department D., St. Hans Mental Hospital, Roskilde, Denmark

    L. Uhrbrand & A. Faurbye

Authors
  1. L. Uhrbrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Faurbye
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Read before the Danish Neurologic Society 25. 1. 1960. Part of the paper read before the Danish Psychiatric Society 2. 5. 1959.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uhrbrand, L., Faurbye, A. Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy. Psychopharmacologia 1, 408–418 (1960). https://doi.org/10.1007/BF00441188

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00441188

Keywords

Search

Navigation